|
John N. Kapoor, Ph.D., is currently Option Care's Chairman of the Board, a position he has held since October 1990. Dr. Kapoor also served as Option Care’s Chief Executive Officer from June 2000 to March 2001, August 1993 to April 1996, and as President from August 1993 through October 1993, and from January 1995 through February 1996.
Since 1990, Dr. Kapoor has served as President of EJ Financial Enterprises, Inc., a provider of funds and strategic advice to start-up and early stage health care concerns that display high growth potential. EJ Financial has made investments in publicly traded companies including Akorn, Inc., which manufactures, markets and distributes sterile ophthalmic and injectable pharmaceuticals and markets and distributes an extensive line of ophthalmic products; NeoPharm, Inc., a pharmaceutical company engaged in the research and development of drugs for the diagnosis and treatment of various forms of cancer; First Horizon Pharmaceutical, Inc., a specialty pharmaceutical company focused on developing, marketing and selling differentiated branded prescription pharmaceuticals for treatment of chronic diseases and Introgen Therapeutics, Inc., a leader in the development and production of gene-based drugs for the treatment of cancer and other diseases. In addition, Dr. Kapoor held several positions with Lyphomed, Inc., including Chairman, Chief Executive Officer and President.
Dr. Kapoor received his Ph.D. in medicinal chemistry from the State University of New York and a B.Sc. (Tech) in Pharmacy from the University Department of Chemical Technology at Bombay.
| 